# Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes

> **NCT02015299** · PHASE3 · COMPLETED · sponsor: **dr. DJ Mulder** · enrollment: 45 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Linagliptin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02015299
- **Lead sponsor:** dr. DJ Mulder
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015299, "Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02015299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*